keyword
https://read.qxmd.com/read/38655986/aortic-stiffness-and-the-response-to-phosphodiesterase-5-inhibitors-in-patients-receiving-treatment-for-erectile-dysfunction-predictive-role-or-an-epiphenomenon
#1
EDITORIAL
Eduardo Tibiriça
No abstract text is available yet for this article.
2024: Arquivos Brasileiros de Cardiologia
https://read.qxmd.com/read/38652285/a-novel-framework-for-functional-annotation-of-variants-of-uncertain-significance-in-id-asd-risk-gene-cc2d1a
#2
JOURNAL ARTICLE
Aniket Bhattacharya, Paola Parlanti, Luca Cavallo, Edward Farrow, Tyler Spivey, Alessandra Renieri, Francesca Mari, M Chiara Manzini
Intellectual disability (ID) and autism spectrum disorder (ASD) are genetically heterogeneous with hundreds of identified risk genes, most affecting only a few patients. Novel missense variants in these genes are being discovered as clinical exome sequencing is now routinely integrated into diagnosis, yet most of them are annotated as variants of uncertain significance (VUS). VUSs are a major roadblock in using patient genetics to inform clinical action. We developed a framework to characterize VUSs in Coiled-coil and C2 domain containing 1A (CC2D1A), a gene causing autosomal recessive ID with comorbid ASD in 40% of cases...
April 23, 2024: Human Molecular Genetics
https://read.qxmd.com/read/38651512/an-update-on-topical-therapies-for-psoriasis
#3
JOURNAL ARTICLE
Emily K Pender, Brian Kirby
PURPOSE OF REVIEW: Topical therapies are a mainstay of treatment for mild psoriasis and may be a useful adjunct in treatment of moderate-to-severe psoriasis. This review summarizes recent advances in topical therapies for psoriasis and currently available treatments. RECENT FINDINGS: Topical aryl hydrocarbon receptor modulators (tapinarof) and topical phosphodiesterase-4 inhibitors (roflumilast) have been proven effective in randomized controlled trials for psoriasis...
April 24, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38647527/secondary-messenger-signalling-influences-pseudomonas-aeruginosa-adaptation-to-sinus-and-lung-environments
#4
JOURNAL ARTICLE
Dilem Ruhluel, Lewis Fisher, Thomas E Barton, Hollie Leighton, Sumit Kumar, Paula Amores Morillo, Siobhan O'Brien, Joanne L Fothergill, Daniel R Neill
Pseudomonas aeruginosa is a cause of chronic respiratory tract infections in people with cystic fibrosis (CF), non-CF bronchiectasis and chronic obstructive pulmonary disease. Prolonged infection allows accumulation of mutations and horizontal gene transfer, increasing the likelihood of adaptive phenotypic traits. Adaptation is proposed to arise first in bacterial populations colonising upper airway environments. Here, we model this process using an experimental evolution approach. P. aeruginosa PAO1, which is not airway adapted, was serially passaged, separately, in media chemically reflective of upper or lower airway environments...
April 22, 2024: ISME Journal
https://read.qxmd.com/read/38644709/the-ift80-hedgehog-pathway-regulates-the-osteogenic-adipogenic-differentiation-of-bone-marrow-mesenchymal-stem-cells
#5
JOURNAL ARTICLE
Mingyang Jiang, Ke Zhang, Yang Hu, Shenyi Lu, Guiqing Wei, Kaicheng Liu, Chuanliang Chen, Xiaochong Zou, Yongheng Dai, Ying Gui, Jing Wu, Huan Bo, Zhandong Bo
BACKGROUND: Steroid-induced avascular necrosis of the femoral head (SANFH) is a typical refractory disease that often progresses irreversibly and has a high disability rate. Numerous studies have confirmed that abnormal osteogenic-adipogenic differentiation of bone marrow mesenchymal stem cells (BM-MSCs) is one of the major factors of SANFH. However, the mechanism remains to be elucidated. OBJECTIVES: This study aimed to investigate the function of the IFT80/Hedgehog pathway in the osteogenic-adipogenic differentiation of BM-MSCs...
April 18, 2024: Current Medicinal Chemistry
https://read.qxmd.com/read/38644056/a-comprehensive-history-of-injection-therapy-for-erectile-dysfunction-1982-2023
#6
JOURNAL ARTICLE
Hartmut Porst, Ronald Lewis, Ronald Virag, Irwin Goldstein
INTRODUCTION: Although oral phosphodiesterase 5 inhibitors represent a first choice and long-term option for about half of all patients with erectile dysfunction (ED), self-injection therapy with vasoactive drugs remains a viable alternative for all those who are not reacting or cannot tolerate oral drug therapy. This current injection therapy has an interesting history beginning in 1982. OBJECTIVES: To provide a comprehensive history of self-injection therapy from the very beginnings in 1982 by contemporary witnesses and some members of the International Society for Sexual Medicine's History Committee, a complete history of injection therapy is prepared from eyewitness accounts and review of the published literature on the subject, as well as an update of the current status of self-injection therapy...
April 21, 2024: Sexual Medicine Reviews
https://read.qxmd.com/read/38639587/-research-progress-of-combination-therapy-in-the-treatment-of-erectile-dysfunction-and-premature-ejaculation-comorbidity
#7
JOURNAL ARTICLE
Jing Peng, Zhi-Chao Zhang
There is a close relationship between male erectile dysfunction (ED) and premature ejaculation (PE) on the pathogenesis, leading a high comorbidity rate and a need of simultaneous treatment in clinical practice. Phosphodiesterase 5 inhibitors (PDE5i) and selective serotonin reuptake inhibitor (SSRI) Dapoxetine are first-line oral drugs for ED and PE, respectively. In recent years, multi-country clinical guidelines have provided suggestions and guidance for the combination of these two drugs, with the safety and effectiveness being further explored and verified...
September 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38639275/identification-of-critical-genes-differentiating-stable-and-unstable-atherosclerotic-plaques-a-bioinformatic-and-computational-analysis
#8
JOURNAL ARTICLE
Maryam Mahjoubin-Tehran, Raul D Santos, Wael Almahmeed, Khalid Al-Rasadi, Amirhossein Sahebkar
BACKGROUND: Identification of biomarkers to distinguish between stable and unstable plaque formation would be very useful to predict plaque vulnerability. METHODS: We downloaded microarray profiles of gene set enrichment (GSE) accession numbers including GSE71226 and GSE20680 (group A: containing healthy vs stable plaque samples) and GSE62646 and GSE34822 (group B: containing stable vs unstable plaque samples) from Gene expression omnibus (GEO) database. Differentially expressed genes were compared in both data sets of each group...
April 18, 2024: Current Vascular Pharmacology
https://read.qxmd.com/read/38637154/circuit-wide-gene-network-analysis-reveals-sex-specific-roles-for-phosphodiesterase-1b-in-cocaine-addiction
#9
JOURNAL ARTICLE
Collin D Teague, Tamara Markovic, Xianxiao Zhou, Freddyson J Martinez-Rivera, Angelica Minier-Toribio, Alexander Zinsmaier, Nathalia V Pulido, Kyra H Schmidt, Kelsey E Lucerne, Arthur Godino, Yentl Y van der Zee, Aarthi Ramakrishnan, Rita Futamura, Caleb J Browne, Leanne M Holt, Yun Young Yim, Corrine H Azizian, Deena M Walker, Li Shen, Yan Dong, Bin Zhang, Eric J Nestler
Cocaine use disorder is a significant public health issue without an effective pharmacological treatment. Successful treatments are hindered in part by an incomplete understanding of the molecular mechanisms that underlie long-lasting maladaptive plasticity and addiction-like behaviors. Here, we leverage a large RNA-sequencing dataset to generate gene co-expression networks across 6 interconnected regions of the brain's reward circuitry from mice that underwent saline or cocaine self-administration. We identify phosphodiesterase 1b ( Pde1b ), a Ca2+ /calmodulin-dependent enzyme that increases cAMP and cGMP hydrolysis, as a central hub gene within a nucleus accumbens (NAc) gene module that was bioinformatically associated with addiction-like behavior...
April 18, 2024: Journal of Neuroscience
https://read.qxmd.com/read/38636573/future-aspects-of-plant-derived-bioactive-metabolites-as-therapeutics-to-combat-benign-prostatic-hyperplasia
#10
REVIEW
Raman Krishnamoorthi, Anand Ganapathy A, Hari Priya V M, Alaganandam Kumaran
ETHNOPHARMACOLOGICAL RELEVANCE: Benign prostatic hyperplasia (BPH), characterized by prostate enlargement due to cell proliferation, is a common urinary disorder in men over 50, manifesting as lower urinary tract symptoms (LUTS). Currently, several therapeutic options are accessible for treating BPH, including medication therapy, surgery and watchful waiting. Conventional drugs such as finasteride and dutasteride are used as 5α-reductase inhibitors for the treatment of BPH. However long-term use of these drugs is restricted due to their unpleasant side effects...
April 16, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38633304/case-report-treatment-of-psoriasiform-dermatitis-in-patients-with-malignancy
#11
Jinzhu Mao, Na Du, Yuanyuan Jia, Qiuyu Mao, Jingyi Yang, Yiwen Zhang, Yueyue Li, Lei Cao, Wei Min
Psoriasis and atopic dermatitis (AD) are prevalent inflammatory skin disorders, each stemming from diverse factors, and characterized by recurring episodes. In certain complex cases, the clinical and pathological features exhibit overlapping and atypical characteristics, making accurate clinical diagnosis and targeted treatment a challenge. Psoriasiform dermatitis is the term used to describe such cases. Moreover, when patients have a history of malignancy, the situation becomes even more intricate, resulting in limited treatment options...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38631990/a-phosphodiesterase-4-pde4-inhibitor-amlexanox-reduces-neuroinflammation-and-neuronal-death-after-pilocarpine-induced-seizure
#12
JOURNAL ARTICLE
Hyun Wook Yang, A Ra Kho, Song Hee Lee, Beom Seok Kang, Min Kyu Park, Chang Jun Lee, Se Wan Park, Seo Young Woo, Dong Yeon Kim, Hyun Ho Jung, Bo Young Choi, Won Il Yang, Hong Ki Song, Hui Chul Choi, Jin Kyu Park, Sang Won Suh
Epilepsy, a complex neurological disorder, is characterized by recurrent seizures caused by aberrant electrical activity in the brain. Central to this study is the role of lysosomal dysfunction in epilepsy, which can lead to the accumulation of toxic substrates and impaired autophagy in neurons. Our focus is on phosphodiesterase-4 (PDE4), an enzyme that plays a crucial role in regulating intracellular cyclic adenosine monophosphate (cAMP) levels by converting it into adenosine monophosphate (AMP). In pathological states, including epilepsy, increased PDE4 activity contributes to a decrease in cAMP levels, which may exacerbate neuroinflammatory responses...
April 16, 2024: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://read.qxmd.com/read/38630428/effect-of-theophylline-on-stent-related-symptoms-in-patients-undergoing-double-j-ureteral-stent-insertion-a-randomized-controlled-trial
#13
JOURNAL ARTICLE
Alireza Pakdel, Abdolreza Mohammadi, Hossein Chivaee, Amirreza Shamshirgaran, Hossein Amirzargar, Reza Mohammadi Farsani, Fardin Asgari, Alireza Khajavi, Seyed Mohammad Kazem Aghamir
PURPOSE: To investigate the effect of oral theophylline on stent-related syndrome (SRS) after Double-J insertion. BACKGROUND: Double-J stent is widely using in many urological procedures. Infection, hematuria, and discomfort are some of common complication after stenting. Theophylline is a dimethylated xanthine that inhibits phosphodiesterase and blocks adenosine receptors. To relaxing effect of theophylline on smooth muscles and its effects on the urinary system, it seems it could reduce complications after inserting Double-J stent especially ureteral stent syndrome...
April 17, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38629860/research-progress-on-the-therapeutic-application-of-extracellular-vesicles-in-erectile-dysfunction
#14
JOURNAL ARTICLE
Xiaolin Zhang, Mengbo Yang, Xinda Chen, Mujun Lu
Erectile dysfunction (ED) is one of the most common male sexual dysfunctions and is related to many pathogenic factors. However, first-line treatment, represented by phosphodiesterase 5 inhibitors, is unable to maintain long-term efficacy. Extracellular vesicles (EVs) have recently attracted the attention of researchers in the fields of cardiovascular disease, neurologic disease, and regenerative medicine and may become a treatment for ED. This article reviews recent applications of EVs in the treatment of ED from the aspects of the source, the therapeutic mechanism, and the strategies to enhance therapeutic efficacy...
April 17, 2024: Sexual Medicine Reviews
https://read.qxmd.com/read/38628658/selected-markers-of-ovarian-cancer-and-their-relation-to-targeted-therapy-review
#15
REVIEW
Anna Markowska, Zbigniew Kojs, Damian Twardawa, Joanna Pietras, Janina Markowska
Despite advances in surgical treatment techniques and chemotherapy-including anti-angiogenic and immune poly (ADP-ribose) polymerase inhibitors, the 5-year survival rate in ovarian cancer (OC) remains low. The reasons for this are the diagnosis of cancer in advanced clinical stages, chemoresistance and cancer recurrence. New therapeutic approaches are being developed, including the search for new biomarkers that are also targets for targeted therapy. The present review describes new molecular markers with relevance to targeted therapy, which to date have been studied only in experimental research...
May 2024: Experimental and Therapeutic Medicine
https://read.qxmd.com/read/38627631/effects-of-pde-3-inhibition-in-persistent-post-traumatic-headache-evidence-of-camp-dependent-signaling
#16
RANDOMIZED CONTROLLED TRIAL
Haidar M Al-Khazali, Rune H Christensen, Basit Ali Chaudhry, Anna G Melchior, Messoud Ashina, Rami Burstein, Håkan Ashina
BACKGROUND: Phosphodiesterase 3 (PDE-3) inhibition have been implicated in the neurobiologic underpinnings of migraine. Considering the clinical similarities between migraine and persistent post-traumatic headache (PPTH), we aimed to ascertain whether PDE-3 inhibition can elicit migraine-like headache in persons with PPTH. METHODS: We tested cilostazol, which inhibits PDE-3, in a randomized, double-blind, placebo-controlled, two-way crossover study involving persons with PPTH attributed to mild traumatic brain injury...
April 17, 2024: Journal of Headache and Pain
https://read.qxmd.com/read/38622307/targeting-phosphodiesterase-4-as-a-potential-therapy-for-parkinson-s-disease-a-review
#17
REVIEW
Pooja Devi Nongthombam, Reena Haobam
Phosphodiesterases (PDEs) have become a promising therapeutic target for various disorders. PDEs are a vast and diversified family of enzymes that degrade cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which have several biochemical and physiological functions. Phosphodiesterase 4 (PDE4) is the most abundant PDE in the central nervous system (CNS) and is extensively expressed in the mammalian brain, where it catalyzes the hydrolysis of intracellular cAMP. An alteration in the balance of PDE4 and cAMP results in the dysregulation of different biological mechanisms involved in neurodegenerative diseases...
April 15, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38621596/transcriptomic-analysis-of-hek293a-cells-with-a-crispr-cas9-mediated-tdp1-knockout
#18
JOURNAL ARTICLE
Nadezhda S Dyrkheeva, Alexandra L Zakharenko, Anastasia A Malakhova, Larisa S Okorokova, Dmitry N Shtokalo, Sergey P Medvedev, Alexey A Tupikin, Marsel R Kabilov, Olga I Lavrik
Tyrosyl-DNA phosphodiesterase 1 (TDP1) is a human DNA repair protein. It is a member of the phospholipase D family based on structural similarity. TDP1 is a key enzyme of the repair of stalled topoisomerase 1 (TOP1)-DNA complexes. Previously, with the CRISPR/Cas9 method, we obtained HEK293A cells with a homozygous knockout of the TDP1 gene and used the TDP1 knockout cells as a cellular model for studying mechanisms of action of an anticancer therapy. In the present work, we hypothesized that the TDP1 knockout would alter the expression of DNA repair-related genes...
April 13, 2024: Biochimica et Biophysica Acta. General Subjects
https://read.qxmd.com/read/38618480/current-and-novel-treatment-modalities-of-idiopathic-pulmonary-fibrosis
#19
REVIEW
Mahnoor Arshad, Zoraize Moeez Athar, Tasneem Hiba
Idiopathic pulmonary fibrosis (IPF) presents a clinical challenge characterized by progressive fibrosis and destruction of lung tissue. Despite recent advancements, including antifibrotic medications like pirfenidone and nintedanib, IPF remains a chronic and often fatal condition with limited treatment options. This article provides an overview of the current treatment modalities for IPF and explores the need for new therapeutic approaches. Antifibrotic medications have shown efficacy in slowing disease progression but are not curative and may not be suitable for all patients...
March 2024: Curēus
https://read.qxmd.com/read/38617664/identification-of-novel-quinolone-and-quinazoline-alkaloids-as-phosphodiesterase-10a-inhibitors-for-parkinson-s-disease-through-a-computational-approach
#20
JOURNAL ARTICLE
Iqra Ahmad, Hira Khalid, Asia Perveen, Muhammad Shehroz, Umar Nishan, Faiz Ur Rahman, Sheheryar, Arlindo Alencar Moura, Riaz Ullah, Essam A Ali, Mohibullah Shah, Suvash Chandra Ojha
Phosphodiesterases (PDEs) are vital in signal transduction, specifically by hydrolyzing cAMP and cGMP. Within the PDE family, PDE10A is notable for its prominence in the striatum and its regulatory function over neurotransmitters in medium-spiny neurons. Given the dopamine deficiency in Parkinson's disease (PD) that affects striatal pathways, PDE10A inhibitors could offer therapeutic benefits by modulating D1 and D2 receptor signaling. This study was motivated by the successful history of quinazoline/quinazoline scaffolds in the inhibition of PDE10A...
April 9, 2024: ACS Omega
keyword
keyword
49410
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.